Novartis Venture Fund invests in early-stage biotechnology and healthcare startups with transformative potential. The firm provides funding and mentorship to foster innovation. It collaborates with entrepreneurs to develop impactful solutions for healthcare challenges.

Contact:
Lictstrasse 35 Building WSJ-200
Basel 4002
Switzerland

Phone: 416-132-4621
Fax: 416-132-4867

Team:
Peter Hans Bissinger, Partner

Website:
http://www.venturefund.novartis.com

Company Type:
Venture Capital Firm

Investment Industries:
Biotechnology, Business and consumer products, Computer hardware, Financial services, Healthcare, Industrial and energy products, IT services, Media and entertainment, Medical equipment, Networking, Real estate, Retailing and distribution, Semiconductors, Software, Telecommunications

Investment Stages:
1st round, 2nd round, 3rd round, 4th round and later, Buyout and acquisition, Mezzanine, Pre-IPO, Seed